Concepedia

Publication | Open Access

Can Nifekalant Hydrochloride be Used as a First-Line Drug for Cardiopulmonary Arrest (CPA)?

DOIFull Paper Access

39

Citations

26

References

2005

Year

Koichiro Yoshioka, Mari Amino, Seiji Morita, Yoshihide Nakagawa, Kazutane Usui, Atsuhiko Sugimoto, Atsushi Matsuzaki, Yoshiaki Deguchi, Isotoshi Yamamoto, Sadaki Inokuchi,
Circulation Journal

Abstract

NIF had a favorable defibrillating effect in both CPA groups, and it shows promise of becoming a first-line drug for CPR.

References

YearCitations

Page 1